Literature DB >> 11877569

Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.

Masaru Nakayama1, Ritsuko Katafuchi, Tetsuro Yanase, Kiyoshi Ikeda, Hiroshi Tanaka, Satoru Fujimi.   

Abstract

To clarify factors influencing the response to corticosteroids and subsequent relapses, 62 Japanese adult patients with minimal change nephrotic syndrome were analyzed retrospectively. Five patients experienced remission spontaneously. Fifty-three patients entered complete remission, 3 patients entered partial remission, and 1 patient showed no response to corticosteroids. Fifty-three patients with complete remission were divided into two groups: 38 early responders who experienced remission completely within 8 weeks after starting treatment and 15 late responders who experienced remission after 8 weeks. Blood urea nitrogen and serum creatinine levels and proteinuria selectivity index at presentation were significantly worse in late than early responders. Relative interstitial volume determined by the point-counting method was significantly greater in late than early responders. Relative interstitial volume showed significant correlations with blood urea nitrogen, serum creatinine, and proteinuria selectivity index values. Thirty-three patients experienced a relapse; 13 patients experienced multiple relapses. Fifty-three patients with remission were divided into three groups: 16 patients who experienced relapse within 6 months after the initial response (early relapsers), 17 patients who experienced relapse after 6 months (late relapsers), and 20 patients who did not experience relapse (nonrelapsers). Mean age at onset was younger in early relapsers than late or nonrelapsers. Age at onset correlated inversely with relapse rate in 53 patients with remission and correlated positively with timing of the first relapse in 33 relapsers. It thus was suggested that impaired renal function and poor selectivity of proteinuria, which might be related to interstitial edema, were factors influencing a slower response to corticosteroids. Younger patients had a greater incidence of relapse and were prone to experience relapse earlier. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877569     DOI: 10.1053/ajkd.2002.31400

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  43 in total

1.  The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.

Authors:  Takashi Takei; Minako Koike; Koichi Suzuki; Satsuki Shirota; Mitsuyo Itabashi; Shigeru Ohtsubo; Hidekazu Sugiura; Keiko Suzuki; Chiari Kojima; Masaki Takahashi; Jun Ino; Tetsuya Ogawa; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

Review 2.  Immunopathogenesis of idiopathic nephrotic syndrome with relapse.

Authors:  Djillali Sahali; Kelhia Sendeyo; Melanie Mangier; Vincent Audard; Shao Yu Zhang; Philippe Lang; Mario Ollero; Andre Pawlak
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

3.  New selectivity index calculated using protein fraction as a substitute for the conventional selectivity index.

Authors:  Jun Nakamura; Katsuyuki Nagatoya; Naohiko Fujii; Aki Warada; Atsuyuki Tokuyama; Satoshi Masuyama; Sachio Kajimoto; Ryota Haga; Atsushi Yamauchi
Journal:  Clin Exp Nephrol       Date:  2019-06-06       Impact factor: 2.801

Review 4.  [Minimal change disease and focal segmental glomerulosclerosis].

Authors:  J Müller-Deile; H Schenk; M Schiffer
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

5.  Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.

Authors:  Masafumi Tenta; Haruhito Adam Uchida; Tomokazu Nunoue; Ryoko Umebayashi; Yuka Okuyama; Masashi Kitagawa; Yohei Maeshima; Hitoshi Sugiyama; Jun Wada
Journal:  CEN Case Rep       Date:  2014-12-30

6.  Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Susumu Oseto; Daisuke Mori; Kodo Tomida; Terumasa Hayashi; Masaaki Izumi; Megumu Fukunaga; Atsushi Yamauchi; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2013-03-20       Impact factor: 2.801

7.  [41-year-old female patient with ST-elevation myocardial infarction and multiple arterial emboli].

Authors:  J Bramstedt; J Schröder; R Dissmann
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

8.  [Minimal Change Glomerulonephritis].

Authors:  S Stracke; U Helmchen; C Aymanns; N Kadlec; B Lindemann; S Hüttner; F Keller
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

Review 9.  [Treatment of glomerulonephritis].

Authors:  T Risler; N Braun; C M Erley
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

10.  Corticosteroids vs. corticosteroids plus cycloporin A in adult minimal changes disease.

Authors:  Dimitrios S Goumenos; Pantelitsa Kalliakmani; Eirini Savvidaki; John G Vlachojannis
Journal:  BMC Res Notes       Date:  2009-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.